Drug Name: 

DUPILUMAB*

Drug Description: 
IL-4R Antibody
Target Condition: 
Asthma and Nasal Polyps
Rank: 
25
Phase: 
Phase 3

NOW APPROVED IN THE UNITED STATES

Learn more